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Wednesday, February 11, 2015 597adifferent subunits of the troponin complex (troponin T, troponin I) exert their
effects by altering the apparent TnC calcium sensitivity/exchange kinetics. There
are a number of potential mechanisms that could alter the calcium binding proper-
ties of TnC, potentially the most significant being the ability of the regulatory
domain of TnC to bind the switch peptide region of TnI. We have developed a
rather simple mathematical model that can simulate the steady-state and kinetic
calcium binding properties of a wide assortment of disease-related and post-
translational protein modifications in the isolated troponin complex and reconsti-
tuted thin filament. We propose that roughly half of the studied modifications do
not alter any of the intrinsicTnCcalciumbinding constants but rather alter the abil-
ity of TnC to ‘‘find’’ TnI in the presence of calcium. Considering TnI is essentially
tethered toTnCandcannotdiffuse away in the absenceofcalciumand thatTnI also
binds to actin, we suggest that the apparent calcium binding properties of TnC are
highly dependent upon an ‘‘effective concentration’’ of TnI available to bind TnC.
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Activation of the b-adrenergic signaling pathway in the heart leads to an
increased rate of pressure development in early systole and an acceleration of
relaxation in diastole to increase cardiac output. These effects are mediated by
protein kinase A (PKA), which primarily targets myosin binding protein-c
(MyBP-C) and troponin I (TnI) in the sarcomere for phosphorylation. However,
the relative contributions of MyBP-C and TnI phosphorylation to the b-ad-
renergic-mediated increases in ionotropy and lusitropy remains unclear. To
investigate, we used mice expressing non-phosphorylatable TnI (TnIAla2),
non-phosphorylatable MyBP-C (MyBP-C3SA), and mice expressing non-
phosphorylatable TnI and MyBP-C (TnI Ala2/MyBP-C3SA), as well as control
WT mice. Pressure-volume loop analysis was performed to measure early sys-
tolic pressure development and ventricular relaxation at baseline and in response
to dobutamine (ab-agonist) administration.At baseline therewas nodifference in
systolic pressure development between the groups, but the acceleration of
dp/dtmax after dobutamine administration was blunted in MyBP-C3SA and TnI
Ala2/MyBP-C3SAmice (mmHg/s; 14,41451,016 inWT, 12,9215982 in TnIAla2,
7,8305899 in MyBP-C3SA, and 8,80351,001 in TnI Ala2/MyBP-C3SA after
dobutamine; p<0.05). We examined elastance (E) decay from 75% to 25% of
maximal E (T75-25; normalized to cardiac cycle duration) to measure ventricular
relaxation. At baseline there were no differences between the rate of relaxation in
any of the groups; however, after dobutamine administration MyBP-C3SA and
TnI Ala2/MyBP-C3SA showed a significantly longer relaxation time compared
to WT and TnIAla2 (6.850.3% in WT, 6.950.3% in TnIAla2, 8.350.2% in
MyBP-C3SA, and 8.550.4 in TnI Ala2/MyBP-C3SA after dobutamine; p<0.05).
These results show that MyBP-C phosphorylation is necessary to fully accelerate
contraction and relaxation in response to b-adrenergic signaling.
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Increased cardiac myocyte contractility by the beta-adrenergic system is an
important mechanism to elevate cardiac output to meet greater hemodynamic
load and this process is often depressed in failing hearts. While increased
contractility involves augmented myoplasmic calcium transients, the myofila-
ments also adapt to boost the transduction of the calcium signal. Accordingly,
ventricular contractility is tightly correlated with PKA-mediated phosphoryla-
tion of two myofibrillar proteins, cardiac myosin binding protein-C (cMyBP-C)
and cardiac troponin I (cTnI), implicating these two proteins as important trans-
ducers of hemodynamics to the cardiac sarcomere. Consistent with this, we
have previously found that phosphorylation of myofilament proteins by PKA
(a downstream signaling molecule of the beta-adrenergic system) increased
force, slowed force development rates, sped loaded shortening, and increased
power output in rat skinned cardiac myocyte preparations. Here, we sought
to define molecule-specific mechanisms by which PKA-mediated phosphoryla-
tion modulates these contractile properties. Regarding cTnI, the incorporation
of thin filaments with a majority of unphosphorylated cTnI (as observed in
some models of late stage heart failure) decreased isometric force production
at any given activator [Ca2þ] and these changes were reversed by PKA-mediated phosphorylation in skinned cardiac myocytes. In addition, incorpora-
tion of unphosphorylated cTnI sped rates of force development, which suggests
less cooperative thin filament activation and recruitment of non-cycling cross-
bridges into the pool of cycling cross-bridges, a process that would tend to
depress myocyte force and power. Regarding cMyBP-C, PKA treatment of
slow-twitch skeletal muscle fibers caused phosphorylation of MyBP-C (but
not TnI) and yielded faster loaded shortening velocity and an ~30% increase
in power output. These results add novel insight into the molecular specificity
by which the beta-adrenergic system controls myofibrillar contractility and how
attenuation of PKA-induced phosphorylation of cMyBP-C and cTnI may
contribute to ventricular pump failure.
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Enhanced cardiac contractile function due to increased sarcomere length (SL) is,
in part, mediated by a decrease in the radial distance between myosin heads and
actin. The radial disposition of myosin heads relative to actin is modulated by
cardiac myosin binding protein-C (cMyBP-C), suggesting that cMyBP-C con-
tributes to the length-dependent activation (LDA) in the myocardium. However,
the precise role of cMyBP-C in modulating cardiac LDA is unclear. To deter-
mine the impact of cMyBP-C on LDA, we measured isometric force, myo-
filament Ca2þ-sensitivity (pCa50) and length-dependent crossbridge (XB)
contractile dynamics in skinned ventricular muscle fibers isolated from the
hearts of wild-type (WT) and cMyBP-C knockout (KO) mice, at SL’s 1.9mm
or 2.1mm.Our results show thatmaximal forcewas not significantly different be-
tweenKO andWTfibers. pCa50was not significantly different betweenWT and
KO fibers at long SL (5.8250.02 in WT vs. 5.8750.02 in KO), whereas pCa50
was significantly different betweenWT andKOfibers at short SL (5.7150.02 in
WT vs. 5.8050.01 in KO; p<0.05). The rate of force redevelopment (ktr),
measured at submaximal Ca2þ-activation, was significantly accelerated at short
SL in WT fibers (8.7450.43s-1at 1.9mm vs. 5.7150.40s-1at 2.1mm, p<0.05).
Furthermore, the rates of stretch-induced XB relaxation (krel) and XB recruit-
ment (kdf) were accelerated by 32% and 70%, respectively at short SL in WT
fibers. In contrast, ktr was not significantly different between both SL’s in KO
fibers (8.0350.54s-1at 1.9mm vs. 8.9050.37s-1at 2.1mm). Furthermore, KO fi-
bers did not exhibit length-dependent differences in krel and kdf -suggesting that
LDA is severely depressed in KO fibers. Collectively, our data indicate that
cMyBP-C plays a central role in modulating cardiac LDA.
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The troponin complex is a critical molecular switch involved in transducing the
calcium activating signal into contraction. Troponin I (TnI), the inhibitory sub-
unit of the complex, is phosphorylated as a key regulatory mechanism to alter
the calcium regulation of contraction. Recent work identified a novel phosphor-
ylation of TnI at Tyr-26 that is decreased from its normal basal level in heart
failure with unknown functional effects. Similar to the desensitizing TnI Ser-
23/24 phosphorylation, TnI Tyr-26 is located in the unique cardiac TnI N-ter-
minal extension. Employing TnI containing actual phosphate at Tyr-26 and
Tyr-26 phosphomimetics, we demonstrate that TnI Tyr-26 phosphorylation de-
creases thin filament calcium sensitivity and accelerates deactivation. To assess
the functional integration of TnI Ser-23/24 and Tyr-26 phosphorylation, we
generated recombinant TnI with phosphomimetic substitution at all three resi-
dues. Calcium sensitivity measurements demonstrate no additional effect on
calcium binding to troponin C nor calcium sensitive force development of
the triple phosphomimetic TnI. However, the integration of Tyr-26 with Ser-
23/24 pseudo-phosphorylation further accelerated thin filament deactivation.
The kinase responsible for TnI Tyr-26 phosphorylation remains to be eluci-
dated. Considering that the Src kinase recognition sequence (EEXY) is similar
to that surrounding TnI Tyr-26 when Ser-23/24 are phosphorylated (S(p)S(p)
NY), we hypothesize that Ser-23/24 phosphorylation would exhibit signaling
crosstalk to alter the rate of Tyr-26 phosphorylation. Current efforts are
directed towards determining the ability of Ser-23/24 phosphorylation to modu-
late Src-family kinase phosphorylation of Tyr-26. Our findings suggest that TnI
Tyr-26 phosphorylation in isolation functions similarly to Ser-23/24 N-terminal
598a Wednesday, February 11, 2015phosphorylation to decrease myofilament calcium sensitivity and accelerate
myofilament relaxation. Furthermore, Tyr-26 phosphorylation can buffer the
desensitization of Ser-23/24 phosphorylation while further accelerating thin
filament deactivation upon their integration. Therefore, the functional integ-
ration of TnI phosphorylation may be a common mechanism to modulate
Ser-23/24 phosphorylation function.
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Slow ventricular cardiac myosin (bmys) has three distinct unitary step-sizes,
nominally 3, 5, and 8 nm, that move actin with varying step-frequencies. Ventric-
ular cardiac myosin essential light chain (vELC) has a 43 residue N-terminal
extension that binds actin. The basis for the three unitary steps in cardiac myosin
was proposed to involve actin bindingof the vELCextensionwherein the predom-
inant 5 nm step does not engage the actin/vELC linkage, the slightly less likely 8
nmstep engages actin/vELC linkage facilitating an extra ~19degrees of lever-arm
rotation, and theminor 3 nm step is the unlikely conversion of the 5 nm step to the
full actin/vELC bound 8 nm step. The hypothesis was tested using several cardiac
myosin constructs including a 17 residue N-terminal truncated vELC in porcine
mys (D17) and a 43 residueN-terminal truncated humanvELCexpressed in trans-
genic mouse heart (D43). Mouse myosin heavy chain is the fast isoform (amys).
Cardiacmyosin step-size and relative step-frequencyweremeasured using a high
throughputQdot super-resolution in vitromotility assay.D17 showeda significant
increase to the 5 nm step-frequency and coincident reduction to the 3 and 8 nm
step-frequencies implying a reduction in probability for forming vELC/actin link-
age. Nontransgenic (NTg) and human vELCexpressedamys in transgenicmouse
heart had three unitary step-sizes like those in bmys although step-frequencies in
NTg were redistributed to favor the 8 nm step.D43 showed a significant increase
to the 5 nm step-frequency and a significant reduction to the combined 3 and 8 nm
step-frequency again indicating lower overall probability for forming vELC/actin
linkage.Data strongly supports the hypothesis that the vELCextension is the basis
for three step-sizes in cardiac myosin. Supported by NIH grants R01AR049277,
R01HL095572, and R01HL108343.
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Hypertrophic cardiomyopathy (HCM) is an inherited disease of the heart mus-
cle that affects approximately 1 in 500 individuals. The condition is character-
ized by enlarged cardiac myocytes, thickened ventricular walls, non-compliant
muscle structure, changes in blood pressure, electrical arrhythmias, and short-
ness of breath. The Arg-to-Gln switch at amino acid 403 of beta-myosin heavy
chain (MHC-R403Q) is the most prevalent mutation associated with familial
HCM. Human induced pluripotent stem (iPS) cell-derived cardiomyocytes
can be generated in highly pure and large quantities from both control and
affected individuals to provide a path forward toward better mechanistic under-
standing of complex heart diseases.
Endothelin-1 (ET-1)-induced cardiac hypertrophy in human iPS cell-derived car-
diomyocytes exhibits several classic hallmarks of cardiac hypertrophy including
up-regulation of the fetal gene expression program, cytoskeletal rearrangements,
and an increase in cardiomyocyte cell size (Carlson et al., 2013). Similar to the
induced hypertrophic state, here we describe novel information regarding innate
cardiac hypertrophy associated with MHC-R403Q. iPS cell-derived cardiomyo-
cytes were generated from an MHC-R403Q-positive individual exhibiting the
HCM phenotype. MHC-R403Q cardiomyocytes were generated at high purity
(>95% TNNT-positive), exhibited the expected cardiac morphology, and
showed autonomous contractile activity similar to the control cardiomyocytes
(non-MHC-R403Q). Transcript profiling demonstrated that basal gene expres-
sion of MHC-R403Q cardiomyocytes was similar to control cardiomyocytes
that had been induced with ET-1 into a hypertrophic state. Similarly, basal
BNP levels inMHC-R403Q cardiomyocytes were higher than those of uninduced
control cardiomyocytes. Interestingly, when treated with ET-1, cardiomyocytes
from both backgrounds exhibited increases in BNP expression to similar levels.
These data suggest thatMHC-R403Q cardiomyocytes may have an innate predis-
position toward familial hypertrophic cardiomyopathy and underscore the advan-
tages of modeling cardiovascular disease through the use of iPSC technology.Cytoskeletal-based Intracellular Transport
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Intracellular transport is largely driven by processive microtubule- and actin-
based molecular motors. Non-processive motors have also been localized
to trafficking cargos, but their roles are not well understood. Myosin-Ic
(Myo1c), a non-processive actin motor, functions in a variety of exocytic events,
although the underlying mechanisms are not yet clear. To investigate the inter-
play between myosin-I and the canonical long distance transport motor kinesin-
1, we attached both motor types to lipid membrane-coated bead (MBC) cargo,
using an attachment strategy that allows motors to actively reorganize within the
membrane in response to the local cytoskeletal environment. We compared the
motility of kinesin-1-driven cargos in the absence and presence of Myo1c at en-
gineered actin/microtubule intersections. We found that Myo1c significantly in-
creases the frequency of kinesin-1-driven microtubule-based runs that begin at
actin/microtubule intersections. Myo1c also regulates the termination of proces-
sive runs. Beads with both motors-bound have a significantly higher probability
of pausing at actin/microtubule intersections, remaining tethered for an average
of 20 s, with some pauses lasting longer than 200 s. The actin-binding protein
non-muscle tropomyosin (Tm) provides spatially-specific regulation of inter-
actions between myosin motors and actin filaments in vivo; in vitro, we found
that Tm2 abrogates Myo1c-driven actin gliding. In the crossed-filament assay,
Tm2-actin abolishes Myo1c-specific effects on both run initiation and run termi-
nation. Together these observations suggest Myo1c is important for the selective
initiation and termination of kinesin-driven runs along microtubules at specific
actin filament populations within the cell.
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Mammalian pigmentation is driven by the intercellular transfer of pigment-
containing melanosomes from the tips of melanocyte dendrites to surrounding
keratinocytes. Using time lapse imaging of primarymousemelanocyte/keratino-
cyte co-cultures prepared from transgenic mice (‘‘Holly’’ mice) in which the
plasma membranes of melanocytes and keratinocytes are red and green, respec-
tively, we recently defined an intercellular melanosome transfer pathway that in-
volves the shedding by the melanocyte of melanosome-rich packages, which are
subsequently phagocytosed by the keratinocyte (Wu et al.; PNAS; 2012). Shed-
ding, which occurs primarily at the tips of the melanocyte’s dendrites, involves
adhesion of the dendrite to the keratinocyte, thinning of the dendrite behind the
forming package, and an apparent self-abscission event that deposits a plasma
membrane-enclosed package ofmelanosomes on the surface of the keratinocyte.
After a variable period of time, the keratinocyte then internalizes this package by
phagocytosis, completely the intercellular transfer of pigment. To determine if
this shedding mechanism also drives melanosome transfer in vivo, we have per-
formed time lapse imaging of ear skin on anesthetized Holly mice. The bound-
aries of red melanocytes and green keratinocytes are clearly visible in the skin,
and the distribution and dynamics of black melanosomes inside both cell types
can be followed in three dimensions. Numerous events that occur along the sides
and tips of melanocyte dendrites, and that appear to be abortive shedding events,
have been seen. To augment transfer, which is probably very infrequent in skin,
we have treated the animal’s ear skin with forskolin-containing cream to
augment pigment synthesis and transfer. Recent imaging yielded several transfer
events that involved shedding of a melanosome-rich package by the melanocyte
and subsequent phagocytosis of the package by the keratinocyte, arguing that the
mechanism we defined previously in co culture also occurs in vivo.
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Tauproteins areexpressedabundantly inhumanneurons, and areknown to regulate
the dynamics and structures of cytoskeletal microtubule filaments. Tau mutations
andmisregulation cancause severe neurodegenerative dementiadiseases including
